Rights and Wrongs: Liberals, progressives, and biotechnology
By Will Saletan,
Slate
| 07. 13. 2007
This week, some big thinkers about biotechnology came to Washington for a "progressive bioethics summit." They invited me to go and talk to them. I like these people, but I'm not a progressive. I don't even think the word makes sense. And that made me ask something else: After two and a half years of covering moral debates about stem cells and other technologies, what do I think of this stuff? What the hell am I?
I have problems with liberals. A lot of them talk about religion as though it's a communicable disease. Some are amazingly obtuse to other people's qualms. They show no more interest in an embryo than in a skin cell. It's like I'm picking up a radio signal and they're not. I'd think I was crazy, except that a few billion other people seem to be picking up the same signal. At most liberal bioethics conferences, the main question in dispute, in one form or another, is whether to be more afraid of capitalism or religion.
I also hate the word progressive. It...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...